Horizon Therapeutics
KRYSTEXXA
Manufacturer:
Horizon Therapeutics
Name:
KRYSTEXXA
HCPCS Code Descriptor:
Injection, pegloticase, 1 mg
Category:
J Code
HCPCS:
J2507
NDC(s):
75987-0080-10
Primary Type:
Immunology
Generic Status:
Single-Source
Route of Administration:
Intravenous
About:
KRYSTEXXA is an Immunology drug manufactured by Horizon Therapeutics and administered via the Intravenous route of administration. The J Code: J2507 is aligned to the drug KRYSTEXXA.
Access Pricing and More By Registering
HCPCS Added Date:
1/1/12
HCPCS Effective Date:
1/1/12
HCPCS Short Description:
Pegloticase injection
Billing and Coding Guide:
https://www.krystexxahcp.com/pdf/ICD10BasicsforPayers20140819.pdf, https://www.hzndocs.com/KRYSTEXXA-Coding-Guide.pdf
Patient Assistance:
https://www.krystexxahcp.com/rheumatology/